GENFIT (EPA:GNFT) | WebDisclosure

Basculer en Français

9480	Companies
185524	Keywords
117913	Articles
99371	Press releases

Home
Companies
GENFIT

BRIEF

published on 05/14/2025 at 22:15, 6 months 21 days ago

GENFIT publie son rapport de performance extra-financière 2025 pour 2024

ESG Biopharmaceutique Durabilité Responsabilité D'entreprise GENFIT
BRIEF

published on 05/14/2025 at 22:15, 6 months 21 days ago

GENFIT Releases 2025 Extra-Financial Performance Report for 2024

Sustainability ESG Biopharmaceutical Corporate Responsibility GENFIT
PRESS RELEASE

published on 05/14/2025 at 22:10, 6 months 21 days ago

GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024)
GENFIT publishes 2025 Extra-Financial Performance Report for fiscal year 2024. Focus on sustainability, ESG approach, social responsibility commitment, and liver disease research

Sustainability GENFIT ESG Approach 2025 Extra-Financial Performance Report Liver Disease Research
BRIEF

published on 05/07/2025 at 22:15, 6 months 28 days ago

GENFIT prépare son Assemblée Générale Mixte de juin 2025

Assemblée Générale Biopharmaceutique Documentation GENFIT Vote En Ligne
BRIEF

published on 05/07/2025 at 22:15, 6 months 28 days ago

GENFIT prepares its Combined General Meeting in June 2025

Biopharmaceuticals General Assembly Documentation GENFIT Online Voting
PRESS RELEASE

published on 05/07/2025 at 22:10, 6 months 28 days ago

GENFIT : Assemblée Générale Mixte du 17 juin 2025 — modalités de mise à disposition des documents préparatoires
GENFIT annonce l'Assemblée Générale Mixte du 17 juin 2025 et la mise à disposition des documents préparatoires. Retransmission en ligne et vote par Internet disponibles

Assemblée Générale Biopharmaceutique Documents Préparatoires GENFIT Vote En Ligne
PRESS RELEASE

published on 05/07/2025 at 22:10, 6 months 28 days ago

GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents
GENFIT announces Annual Combined General Meeting on June 17, 2025, providing shareholders with preparatory documents and online voting option. Company's focus on liver diseases and diverse R&D portfolio highlighted

Shareholders Annual Meeting Liver Diseases GENFIT R&D Portfolio
BRIEF

published on 05/05/2025 at 07:35, 7 months ago

GENFIT présentera la recherche ACLF au Congrès EASL 2025

Biopharmaceutique GENFIT Congrès De L'EASL Recherche De L'ACLF Hépatologie
BRIEF

published on 05/05/2025 at 07:35, 7 months ago

GENFIT to Showcase ACLF Research at EASL Congress 2025

Biopharmaceutical GENFIT EASL Congress ACLF Research Hepatology
PRESS RELEASE

published on 05/05/2025 at 07:30, 7 months ago

GENFIT to Present Latest ACLF Research at EASL Congress 2025
GENFIT to Present Latest ACLF Research at EASL Congress 2025. Six posters on ACLF and diagnostic models. Events include EASL Studio and ACLF Patient Advocacy Council session

Research GENFIT ACLF EASL Congress Posters

Accesswire

Published on 12/05/2025 at 18:45, 13 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 38 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 58 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 1 hour 43 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 1 hour 58 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:26, 31 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 42 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 1 hour 6 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 1 hour 11 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:00, 1 hour 57 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance

Les Echos

Published on 12/05/2025 at 17:18, 1 hour 40 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 1 hour 40 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 3 hours 47 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 3 hours 47 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 4 hours 59 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE